Pseudomonas in augmented care: should we worry?

  title={Pseudomonas in augmented care: should we worry?},
  author={Michael Kelsey},
  journal={The Journal of antimicrobial chemotherapy},
  volume={68 12},
The problem of Pseudomonas as a nosocomial pathogen is not new, with some authors dating its onset to the start of the antimicrobial era, although other factors, such as the growth of intensive or augmented care, have a part to play. This paper outlines the historical and environmental issues that may be associated with a potential increase in the incidence of this difficult-to-treat pathogen.